Avid Bio’s 2024 rev­enue drops; Lotte Bio breaks ground on new $3.3B site 

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

Avid Bioser­vices’ rev­enue for fis­cal year …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.